These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 31926762)

  • 1. Comparison of the prognostic value of ECOG-PS, mGPS and BMI/WL: Implications for a clinically important framework in the assessment and treatment of advanced cancer.
    Dolan RD; Daly L; Sim WMJ; Fallon M; Ryan A; McMillan DC; Laird BJ
    Clin Nutr; 2020 Sep; 39(9):2889-2895. PubMed ID: 31926762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Relationship between ECOG-PS, mGPS, BMI/WL Grade and Body Composition and Physical Function in Patients with Advanced Cancer.
    Dolan RD; Daly LE; Simmons CP; Ryan AM; Sim WM; Fallon M; Power DG; Wilcock A; Maddocks M; Bennett MI; Usborne C; Laird BJ; McMillan DC
    Cancers (Basel); 2020 May; 12(5):. PubMed ID: 32397102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the prognostic value of MUST, ECOG-PS, mGPS and CT derived body composition analysis in patients with advanced lung cancer.
    Abbass T; Dolan RD; MacLeod N; Horgan PG; Laird BJ; McMillan DC
    Clin Nutr ESPEN; 2020 Dec; 40():349-356. PubMed ID: 33183562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammation and Performance Status: The Cornerstones of Prognosis in Advanced Cancer.
    Rocha BMM; Dolan RD; Paiva CE; McGovern J; Paiva BSR; Preto DD; McMillan DC; Maia YCP; Laird BJ
    J Pain Symptom Manage; 2023 Apr; 65(4):348-357. PubMed ID: 36493981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. "How Long Have I Got?"-A Prospective Cohort Study Comparing Validated Prognostic Factors for Use in Patients with Advanced Cancer.
    Simmons C; McMillan DC; Tuck S; Graham C; McKeown A; Bennett M; O'Neill C; Wilcock A; Usborne C; Fearon KC; Fallon M; Laird BJ;
    Oncologist; 2019 Sep; 24(9):e960-e967. PubMed ID: 30975922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determinants of quality of life in patients with incurable cancer.
    Daly LE; Dolan RD; Power DG; Ní Bhuachalla É; Sim W; Cushen SJ; Fallon M; Simmons C; McMillan DC; Laird BJ; Ryan AM
    Cancer; 2020 Jun; 126(12):2872-2882. PubMed ID: 32267548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modified Glasgow Prognostic Score, Prognostic Nutritional Index and ECOG Performance Score Predicts Survival Better than Sarcopenia, Cachexia and Some Inflammatory Indices in Metastatic Gastric Cancer.
    Demirelli B; Babacan NA; Ercelep Ö; Öztürk MA; Kaya S; Tanrıkulu E; Khalil S; Hasanov R; Alan Ö; Telli TA; Koca S; Arıbal ME; Kuzan B; Dane F; Yumuk PF
    Nutr Cancer; 2021; 73(2):230-238. PubMed ID: 32270713
    [No Abstract]   [Full Text] [Related]  

  • 8. An exploratory study examining the relationship between performance status and systemic inflammation frameworks and cytokine profiles in patients with advanced cancer.
    Dolan RD; Laird BJA; Klepstad P; Kaasa S; Horgan PG; Paulsen Ø; McMillan DC
    Medicine (Baltimore); 2019 Sep; 98(37):e17019. PubMed ID: 31517821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical utility of the pretreatment glasgow prognostic score in patients with advanced inoperable non-small cell lung cancer.
    Leung EY; Scott HR; McMillan DC
    J Thorac Oncol; 2012 Apr; 7(4):655-62. PubMed ID: 22425914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognosis in advanced lung cancer--A prospective study examining key clinicopathological factors.
    Simmons CP; Koinis F; Fallon MT; Fearon KC; Bowden J; Solheim TS; Gronberg BH; McMillan DC; Gioulbasanis I; Laird BJ
    Lung Cancer; 2015 Jun; 88(3):304-9. PubMed ID: 25870155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of systemic inflammation and for patients with colorectal cancer cachexia.
    Ruan GT; Xie HL; Yuan KT; Lin SQ; Zhang HY; Liu CA; Shi JY; Ge YZ; Song MM; Hu CL; Zhang XW; Liu XY; Yang M; Wang KH; Zheng X; Chen Y; Hu W; Cong MH; Zhu LC; Deng L; Shi HP
    J Cachexia Sarcopenia Muscle; 2023 Dec; 14(6):2813-2823. PubMed ID: 37902006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic factors in patients with advanced cancer: a comparison of clinicopathological factors and the development of an inflammation-based prognostic system.
    Laird BJ; Kaasa S; McMillan DC; Fallon MT; Hjermstad MJ; Fayers P; Klepstad P
    Clin Cancer Res; 2013 Oct; 19(19):5456-64. PubMed ID: 23938289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship between the BMI-adjusted weight loss grading system and quality of life in patients with incurable cancer.
    Daly L; Dolan R; Power D; Ní Bhuachalla É; Sim W; Fallon M; Cushen S; Simmons C; McMillan DC; Laird BJ; Ryan A
    J Cachexia Sarcopenia Muscle; 2020 Feb; 11(1):160-168. PubMed ID: 31692296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of the modified Glasgow Prognostic Score (mGPS) in recurrent ovarian cancer (ROC) - Analysis of patients enrolled in the GCIG Symptom Benefit Study (SBS).
    Roncolato FT; Berton-Rigaud D; O'Connell R; Lanceley A; Sehouli J; Buizen L; Okamoto A; Aotani E; Lorusso D; Donnellan P; Oza A; Avall-Lundqvist E; Berek J; Hilpert F; Ledermann JA; Kaminsky MC; Stockler MR; King MT; Friedlander M
    Gynecol Oncol; 2018 Jan; 148(1):36-41. PubMed ID: 29107348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphocyte to Monocyte Ratio and Modified Glasgow Prognostic Score Predict Prognosis of Lung Adenocarcinoma Without Driver Mutation.
    Minami S; Ihara S; Kim SH; Yamamoto S; Komuta K
    World J Oncol; 2018 Feb; 9(1):13-20. PubMed ID: 29581811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship between
    Dolan RD; Maclay JD; Abbass T; Colville D; Buali F; MacLeod N; McSorley ST; Horgan PG; McMillan DC
    Sci Rep; 2020 Nov; 10(1):20819. PubMed ID: 33257741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nutritional and inflammatory measures predict survival of patients with stage IV colorectal cancer.
    Takamizawa Y; Shida D; Boku N; Nakamura Y; Ahiko Y; Yoshida T; Tanabe T; Takashima A; Kanemitsu Y
    BMC Cancer; 2020 Nov; 20(1):1092. PubMed ID: 33176752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship between the insulin-like growth factor-1 axis, weight loss, an inflammation-based score and survival in patients with inoperable non-small cell lung cancer.
    Meek CL; Wallace AM; Forrest LM; McMillan DC
    Clin Nutr; 2010 Apr; 29(2):206-9. PubMed ID: 19748165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are CT-Derived Muscle Measurements Prognostic, Independent of Systemic Inflammation, in Good Performance Status Patients with Advanced Cancer?
    McGovern J; Dolan RD; Simmons C; Daly LE; Ryan AM; Power DG; Fallon MT; Laird BJ; McMillan DC
    Cancers (Basel); 2023 Jul; 15(13):. PubMed ID: 37444607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic criteria for the classification of cancer-associated weight loss.
    Martin L; Senesse P; Gioulbasanis I; Antoun S; Bozzetti F; Deans C; Strasser F; Thoresen L; Jagoe RT; Chasen M; Lundholm K; Bosaeus I; Fearon KH; Baracos VE
    J Clin Oncol; 2015 Jan; 33(1):90-9. PubMed ID: 25422490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.